Common side effects include nausea, dizziness, or diarrhoea, but these gastrointestinal (GI) side effects usually go away as your body gets used to the treatment
Diabetes 68(5):906917 Gentilella R, Pechtner V, Corcos A, Consoli A (2019) Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same
Single-use, pre-filled pens contain doses of: 0.25 mg per pen 0.5 mg per pen 1 mg per pen 1.7 mg per pen 2.4 mg per pen Pre-filled, multi-use pens contain the doses of: 1 mg per pen 2 mg per pen 4 mg per pen 6.8 mg per pen 9.6 mg per pen The inactive ingredients include: Sodium chloride (8.25 mg) Disodium phosphate dihydrate (1.42 mg) Water for injection In addition to these, sodium hydroxide or hydrochloric acid can also be added as per the requirement to adjust pH
Similar content being viewed by others Introduction Glucagon like peptide 1 receptor agonists (GLP-1RA) are medications used as a treatment for type 2 diabetes mellitus (T2DM) and obesity
Still, the experts would now like to compare these results in future trials with existing GLP-1 treatments and open the experiment up to different weight bands to see who can benefit the most
Journal of School Nursing 27(5):348-354
